Avalo Therapeutics Chairman Simon Pedder's 2019 pay jumps 13,562% to $3.8M
Avalo Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Avalo Therapeutics reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, four executives at Avalo Therapeutics received on average a compensation package of $1.8M, a 59% increase compared to previous year.
Average pay of disclosed executives at Avalo Therapeutics
Simon Pedder, Chairman, received $3.8M in total, which increased by 13,562% compared to 2018. 49% of Pedder's compensation, or $1.9M, was in option awards. Pedder also received $158K in bonus, $248K in salary, $1.2M in stock awards, as well as $270K in other compensation.
Pericles Calias, Chief Scientific Officer, received a compensation package of $1.3M, which increased by 283% compared to previous year. 49% of the compensation package, or $657K, was in option awards.
Joseph M. Miller, Chief Financial Officer, earned $1.2M in 2019, a 74% increase compared to previous year.
Peter Greenleaf, Chief Executive Officer, received $735K in 2019, which decreases by 86% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 28, 2020.